Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes

Journal of Dermatological Treatment

Volumn 13, Issue 3, 2002, Pages 107-110

  Gans, Eh ^a,b   Kligman, Am ^c  

^a Hastings Senior Associates LLC   (United States)

^b Medicis Pharmaceutical Corporation   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Benzoyl Peroxide; Cleocin T; Clindamycin; P. acnes; Suppression; Triaz

Indexed keywords

BENZOYL PEROXIDE; CLINDAMYCIN; GLYCOLIC ACID; TRIAZ; UNCLASSIFIED DRUG; ZINC;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; GEL; HUMAN; LOTION; NORMAL HUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; QUANTITATIVE ANALYSIS; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; BENZOYL PEROXIDE; CLINDAMYCIN; FEMALE; HUMANS; PROPIONIBACTERIUM ACNES; SKIN;

EID: 0036738503     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630260199451     Document Type: Article

References (12)

1. Webster GF, Inflammation in acne vulgaris. J Am Acad Dermatol (1995) 33: 247-53.
2. Kligman AM, Tricks and treatments. Part II: the benzoyl peroxide saga. Cutis (1995) 56: 260-1.
3. Christensen M, McCullough J, Rizer R, Gans EH, et al, The comprehensive cutaneous performance of Triaz. (2002; in press).
4. Burke B, Eady EA, Cunliffe WJ, Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris. Br J Dermatol (1983) 108: 199-204.
5. Kirton V, Wilkinson D, Benzoyl peroxide in acne. Practitioner (1979) 204: 683-6.
6. Williamson P, Kligman AM, A new method for the quantitative investigation of cutaneous bacteria. J Invest Dermatol (1965) 45: 498-503.
7. Farmery MR, Jones CE, Eady EA et al, In vitro activity of azaleic acid, benzoyl peroxide and zinc acetate against antibiotic resistant propionibacteria from acne patients. J Dermatol Treat (1994) 5: 63-5.
8. Kligman AM, Comparison of a topical benzoyl peroxide gel, oral minocycline, oral doxycycline and a combination for suppression of P. acnes in acne patients. J Dermatol Treat (1998) 9: 187-91.
9. Leyden J, Levy S, The development of antibiotic resistance in Propionibacterium acnes. Cutis (2001) 2 (suppl): 21-4.
10. Cunliffe WJ, Propionibacterium acnes resistance and its clinical relevance. J Dermatol Treat (1995) 6 (suppl 1): S3-S4.
11. Sklar JL, Jacobsen C, Rizer R, Gans EH, Evaluation of Triaz 10% gel and benzamycin in acne vulgaris. J Dermatol Treat (1966) 7: 147-52.
12. Leyden J, Kaidbey K, In vivo antimicrobial performance of Triaz Cleanser. Clinical Research Department, Medicis Pharmaceutical Co., Inc., Pennsylvania, USA.